CIPLA · NSE · Healthcare

Cipla share analysis

₹1,325-2.4% 1 month

Cipla passes 3 of 5 fundamental tests, a score of 6/10. On the daily chart it is in a sideways range, RSI 40, 21% below its 52-week high: range-bound: no edge either way. Its own volatility puts the likely range at ₹1,248–₹1,407 a month from now and ₹1,076–₹1,632 in a year (68% bands).

Fundamentals 6/10

Market cap
₹1,07,051 Cr
P/E · forward
31.8 · 20.9
PEG · P/B
— · 3.1
ROE · net margin
— · +12%
Revenue · earnings growth
+4% · -39%
Debt / equity
2%
Dividend · beta
1.0% · 0.1
Next results
27 Oct 2026
  • ✓ Net margin above 10%
  • ✕ Revenue growing over 10%
  • ✕ Earnings growing
  • ✓ Debt/equity under 100%
  • ✓ Forward P/E under trailing (earnings expected up)

Swing technicals (daily)

Range-bound: no edge either way
Trend
sideways · 50d above 200d
RSI(14)
40
20 / 50 / 200-day avg
₹1,351 / ₹1,390 / ₹1,372
20-day breakout
above ₹1,421 · below ₹1,292
ATR(14)
₹25.95 (2.0% a day)
52-week range
₹1,166 – ₹1,673
Return 3m · 6m · 1y
-7% · +8% · -15%

What the price could do

InLikely range (68%)
1 mo₹1,248 – ₹1,407 (-6% / +6%)
3 mo₹1,194 – ₹1,470 (-10% / +11%)
6 mo₹1,144 – ₹1,535 (-14% / +16%)
1 year₹1,076 – ₹1,632 (-19% / +23%)

Analysts (36): buy, mean target ₹1,512 (+14%)

From its own volatility (21% a year), no drift assumed: what its swings allow, not a forecast.

Cipla news · last two days

News lean: Neutral
  1. 36h agoCipla explores stent deal talks ahead of results for Cipla stockAd Hoc News
  2. 3d agoCipla stock sits 21.42 percent below its 52-week highAd Hoc News
  3. 5d agoCipla Share Price Highlights: Cipla Stock Price HistoryThe Economic Times
  4. 6d agoTCS, HDFC Life, Cipla - Which stock to buy and sell? Jigar Patel of Anand Rathi suggests strategy - Target, stop lossMint
See CIPLA the way a desk does.

Its order flow and footprint, the AI read of every headline, the expected move, and your own holdings beside it, with your broker connected.

Information and analytics for education only, not investment advice or a recommendation to buy or sell. Alephix Intelligence is not registered with SEBI as an investment adviser or research analyst. Prices may be delayed; figures come from public market data.